康莱特胶丸联合TACE治疗中晚期原发性肝癌的疗效观察OACSTPCD
Effects of kanglaite capsules combined with transcatheter arterial chemoembolization(TACE) on patients with mid or late-stage primary hepatocellular carcinoma(HCC)
Objective:To observe the clinical effects of kanglaite (KLT)capsules combined with transcatheter arterial chemo- embolization(TACE)in treating patients with mid or late-stage primary hepatocellular carcinoma (HCC).Methods:Six…查看全部>>
Objective:To observe the clinical effects of kanglaite (KLT)capsules combined with transcatheter arterial chemo- embolization(TACE)in treating patients with mid or late-stage primary hepatocellular carcinoma (HCC).Methods:Sixty-five cases were randomly divided into 2 groups.32 patients in combination group received the treatment of KLT capsules+TACE and 33 patients in control group were treared with TACE alone.The objective response rate(RR).serum alpha feto…查看全部>>
Daojun Li;Xinhua Xu;Dan Bao;Feng Xue;Delan Dai
The First College of Clinical Medical Science,Three Gorges University,Yichang 443003,ChinaDepartment of Oncology,Yichang Central People's Hospital,Yichang 443003,ChinaOncology Institute,Three Gorges University,Yichang 443003,ChinaDepartment of Oncology,Yichang Central People's Hospital,Yichang 443003,ChinaOncology Institute,Three Gorges University,Yichang 443003,China
药学
kanglaite (KLT) capsulesprimaw hepatocellular carcinoma(HCC)chemotherapyembolization
kanglaite (KLT) capsulesprimaw hepatocellular carcinoma(HCC)chemotherapyembolization
《中德临床肿瘤学杂志（英文版）》 2009 (2)
65-68,4
评论